The PermeAct technology does not affect the compound or carrier vehicle
While GPX4 inhibitors suitable for human translational approaches remain to be developed, our results highlight the kinase PSTK as a novel potentially druggable target for the development of novel ferroptosis inducing agents
Best Weight Loss Medication 2026: Complete GLP-1 Comparison Guide Best Weight Loss Medication 2026: Complete GLP-1 Comparison Guide Tirzepatide (Zepbound, Mounjaro) is the most effective weight loss medication in 2026, producing 15-22% average body weight loss in clinical trials, followed closely by semaglutide (Wegovy, Ozempic) with 10-15% average weight loss, with both significantly outperforming all other FDA-approved weight loss medications
You are not just a passive participant in your treatment
You will need Acrobat Reader to (note:this is a huge file)[13mb]
This clinical trial is continuing, expanding to a larger group of people for a full five years to see if these initial improvements continue